Dirchwolf M, Becchetti C, Gschwend SG, Toso C, Dutkowski P, Immer F, Beyeler F, Rossi S, Schropp J, Dufour JF, Banz V; Swiss Transplant Cohort Study. The MELD upgrade exception: a successful strategy to optimize access to liver transplantation for patients with high waiting list mortality. HPB (Oxford). 2022 Jul;24(7):1168-1176. doi: 10.1016/j.hpb.2021.12.009. Epub 2021 Dec 21. PMID: 35065891.
Becchetti C, Gschwend SG, Dufour JF, Banz V. COVID-19 in Liver Transplant Recipients: A Systematic Review. J Clin Med. 2021 Sep 5;10(17):4015. doi: 10.3390/jcm10174015. PMID: 34501463.
Gavini J, Dommann N, Jakob MO, Keogh A, Bouchez LC, Karkampouna S, Julio MK, Medova M, Zimmer Y, Schläfli AM, Tschan MP, Candinas D, Stroka D, Banz V. Verteporfin-induced lysosomal compartment dysregulation potentiates the effect of sorafenib in hepatocellular carcinoma. Cell Death Dis. 2019 Oct 3;10(10):749. doi: 10.1038/s41419-019-1989-z. PMID: 31582741.